Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Regeneron on Wednesday said the FDA green light covers Lynozyfic in adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a ...

Regeneron on Wednesday said the FDA green light covers Lynozyfic in adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a ...

Although people should have the right to eat soda, candy, and other less nutritious foods, the federal government shouldn't ...

Azurity Pharmaceuticals has received permission from the Food and Drug Administration for Xifyrm (meloxicam injection), an IV non-steroidal anti-inflammatory drug that offers once daily dosing.

The FDA has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs. It’s the first new class of oral antibiotics for UTIs in almost 30 years, according to ...

The Supreme Court declined Monday to consider an appellate court’s 2023 decision overturning portions of an Oklahoma law regulating pharmacy benefit managers.

TULSA, Okla. — The memorial procession held in honor of a fallen Disney firefighter passed through Tulsa. 31-year-old Billy ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of ...

Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease therapy donanemab and will launch it at a cost it claims could deliver savings compared to a rival therapy from ...